In our work advising 600+ startups, the most-active Chicago VCs in 2026 are ARCH Venture Partners, Origin Ventures, New Stack Ventures, MATH Venture Partners, Hyde Park Venture Partners. Chicago's VC scene quietly outperforms its reputation. The cards on this page sync live from our Waveup Copilot database.
Every week we get a Chicago founder asking us: "Do I need to fly to SF to raise, or can I close from Chicago?" The honest answer is — for B2B SaaS and Heartland-anchored plays, Chicago VCs are competitive on Series A. For Series B+, you'll typically need coastal (SF/NYC) lead VCs to lead. Chicago's VC scene quietly outperforms its reputation. Tempus AI IPO'd in June 2024 raising $410M at $6B valuation — Chicago-founded healthcare AI. ARCH Venture Partners deployed $3B+ into life sciences in 2024-2025. Kin Insurance scaled past $200M ARR for direct-to-consumer home insurance. Cresco Labs anchors the cannabis/CPG cluster.

We track active Chicago VCs in our Waveup Copilot database — the cards on this page sync from there weekly, so you're always pitching active funds, not last year's roster. Below is the working shortlist with focus, stage, check size, and live investment activity.
Best 5 Chicago VCs at a glance
- ARCH Venture Partners — Chicago-based life-sciences specialist; 502 investments; backed Illumina, Juno Therapeutics, Beam Therapeutics; multi-stage biotech.
- Origin Ventures — Chicago-based early-stage VC; 120 investments; backed Coyote Logistics, ParkWhiz, Logiq; B2B SaaS and marketplace focus.
- New Stack Ventures — Chicago-based pre-seed and seed VC; 73 investments; B2B SaaS and devtools; Heartland-anchored thesis.
- MATH Venture Partners — Chicago-based growth-stage VC; data/analytics-driven thesis; B2B SaaS and consumer.
- Hyde Park Venture Partners — Chicago-based seed/Series A VC; Midwest-anchored thesis; B2B SaaS, marketplaces, fintech.
Most active Chicago venture capital funds
ARCH Venture Partners, Origin Ventures, New Stack Ventures, MATH Venture Partners, Hyde Park Venture Partners, plus the multi-stage giants writing follow-on checks (Sequoia, a16z, Lightspeed, Accel) and Chicago-anchored corporate strategics. The cards below sync with our database — focus areas, stage focus, and check sizes reflect each fund's current profile.
The widget below shows active Chicago funds with focus areas, stage breakdown, and average check sizes. Click View VC firm on any card to see the fund's full investment profile. We refresh this list weekly so you're never pitching a fund that stopped writing checks 18 months ago.
- AI & Deep Tech
- Advertising & Marketing
- +29
- Pre-Seed
- Seed
- +2
- $0-$100K
- $100K-$500K
- +2
- AI & Deep Tech
- Advertising & Marketing
- +17
- Seed
- Series A
- +2
- $100K-$500K
- $500K-$1M
- +2
- AI & Deep Tech
- Pharma
- +22
- Seed
- Series A
- +1
- $500K-$1M
- $1M-$3M
- +1
- AI & Deep Tech
- Advertising & Marketing
- +30
- Pre-Seed
- Seed
- +2
- $500K-$1M
- $1M-$3M
- +1
- AI & Deep Tech
- Advertising & Marketing
- +25
- Seed
- Series A
- +3
- $1M-$3M
- $3M-$10M
- AI & Deep Tech
- Advertising & Marketing
- +25
- Pre-Seed
- Seed
- +2
- AI & Deep Tech
- Advertising & Marketing
- +24
- Seed
- Series A
- +2
- Food & Beverage
- Consumer Goods & Electronics
- +9
- Seed
- Series A
- +1
- $10M-$50M
- $100K-$500K
Methodology — how we keep this list current
We pulled this list from our Waveup Copilot fund database — VCs cross-checked against Crunchbase, PitchBook, TechCrunch, and the funds' own sites. To make the cut, a fund had to be actively writing Chicago-anchored leads in 2024–2025.
Chicago sub-niches: which one matches your raise?
Chicago VC clusters around four lanes — and the Midwest-anchored thesis is its differentiator: B2B SaaS / vertical SaaS (Origin, New Stack, Hyde Park, MATH) — Heartland operator network. Healthcare / life sciences (ARCH, MATH, Sandbox AQ) — University of Chicago + Northwestern halo. Fintech / insuretech (Kin, Avant DNA, Hyde Park's fintech practice) — financial services Chicago-strength. Logistics / industrial-tech (Origin, Coyote/Cresco DNA) — Midwest manufacturing + logistics adjacency.
Where the money is going in 2025–2026
Chicago's VC scene quietly outperforms its reputation — and 2024-2025 made it impossible to ignore. Tempus AI IPO'd in June 2024 at $6B valuation, raising $410M (NASDAQ: TEM) — Chicago-founded healthcare AI hitting public markets. ARCH Venture Partners deployed $3B+ in life sciences in 2024-2025 — that's the kind of capital scale that makes a city. Kin Insurance scaled past $200M ARR for direct-to-consumer home insurance. Avant continues to scale for consumer credit. Cresco Labs anchors the cannabis/CPG cluster. The pattern we keep telling Midwest founders: Chicago wins on B2B SaaS, healthcare/life sciences, fintech/insuretech, and logistics/industrial — exactly the lanes coastal VCs underrate at seed but lead-fight over at Series B.
Why Chicago founders need Chicago VCs
Chicago VCs do three things distant generalists can't: validate local market signal, unlock Chicago-specific operator and customer intros, and price your round correctly against actual Chicago-comparables. We've watched generalist-led rounds underprice Chicago startups by 25%+ because the lead simply didn't know the comp set or local talent dynamics.
Here's what most Midwest founders we coach miss: the lead investor's reputation does the heavy lifting on follow-on access, Chicago talent recruiting, and enterprise buyer credibility — not the dollars. A strong Chicago lead can compress your time-to-Series-B from 24 months to 12, and dramatically improve the terms when later rounds open. We've watched it happen on 600+ raises across our portfolio.
How to raise venture capital in Chicago in 2026
We've seen Chicago founders close 70% faster when they target local VCs whose check size, stage, and sub-niche actually match — not by mass-DMing 200 partners. Build a tight 12–14-slide pitch deck, benchmark numbers against actual 2025–2026 Chicago comparables, and route the first intro through a portfolio founder, Chicago accelerator alum, or operator angel. Cold reply rates run 1–3%; warm intros run 30%+.
Three steps that actually work for Midwest founders we coach: (1) build a list of 15–25 Chicago-active funds whose check size, stage, and sub-niche match your raise — the cards above tell you exactly that; (2) work warm-intro paths through portfolio founders, Chicago accelerators, and operator angels; (3) tighten your deck to survive a partner's 60-second pattern-match. We've seen this approach compress raise time from 9 months to 4 across our 600+ portfolio.
If you're not sure how to position your Chicago numbers — or whether your deck reads as institutional-ready against the 2025–2026 comp set — our team has helped 600+ startups raise across pre-seed, seed, Series A, and growth. We'll tell you straight whether you're ready or what to fix first.
Related read:
- Top early-stage VC firms
- Top Series A venture capital firms
- Top venture capital firms in NYC
- Top venture capital firms in San Francisco
- Top investors and VC firms in Dubai
- Top venture capital firms in London
Are Chicago VCs the right fit for your raise?
Yes — pitch Chicago VCs
- You have a working product with $10K+ MRR or signed enterprise pilot
- Sector matches active Chicago thesis (B2B SaaS, healthcare/life sciences, fintech/insuretech, logistics/industrial)
- Your team has Heartland operator credibility (ex-Salesforce, Tempus, Cresco, Avant, Kin alumni)
- You can articulate path to coastal-buyer acquisition or coastal-led Series B
- You're raising $250K–$50M (Chicago-typical Series A ceiling, ARCH life-sciences higher)
Not the right fit yet
- Pure consumer DTC without Heartland angle — better positioned in NYC or LA
- Generic AI/ML play without sector wedge — coastal VCs have deeper specialist coverage
- Hardware needing 24+ months to revenue — better positioned in SF or Boston
- Late-stage growth ($50M+ raise) — go to coastal growth-stage VCs
- First-time founder with no Midwest operator network — start with TechNexus, Hyde Park Angels, or 1871 accelerator